Maryland Code, Health-General § 21-2B-02

(1) Provide the manufacturer's investigational drug, biological product, or device to an eligible patient without compensation; or

(2) Subject to subsection (b) of this section, require an eligible patient to pay the costs of or associated with the manufacture of the investigational drug, biological product, or device provided to the eligible patient.

(b)(1) Any payment required by a manufacturer under subsection (a)(2) of this section shall be limited to the recovery of the costs of or associated with the manufacture of the specific investigational drug or biological product dosages or devices provided to the eligible patient.

(2) A manufacturer of an investigational drug, biological product, or device may not profit from providing an investigational drug, biological product, or device provided to an eligible patient.

(d)(1) The Office of the Attorney General shall develop an informed consent form that:

(2) This subsection may not be construed to prohibit a treating physician or a manufacturer of an investigational drug, biological product, or device from including additional information or advisements with the informed consent form developed under paragraph (1) of this subsection.